Calcium desensitization in Smooth Muscle
平滑肌钙脱敏
基本信息
- 批准号:7388268
- 负责人:
- 金额:$ 30.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adrenergic AgentsAdultAffectAffinityAgonistAmino AcidsBindingBlood PressureCalciumCardiovascular PhysiologyCell Surface ReceptorsCell membraneCellsCharacteristicsCholinergic AgentsContractsCyclic AMPCyclic GMPCyclic NucleotidesDiseaseElectron MicroscopyElementsEnzymesEventFamilyFluorescenceGastrointestinal DiseasesGenesGeneticGlaucomaHistocytochemistryHormonesHumanHuman GenomeHypertensionImmuneIndividualKnockout MiceLeadMass Spectrum AnalysisMechanicsMediatingMolecularMolecular BiologyMusMuscleMuscle FibersMuscle ProteinsMuscle functionMuscle relaxation phaseNeuronsNeurotransmittersOrganellesPatternPharmaceutical PreparationsPhenotypePhosphoproteinsPhosphorylationPhosphorylation SitePhysiologicalPhysiological ProcessesPhysiologyPlayProcessPropertyProtein KinaseProteinsProteomicsPurposeRegulationRelaxationResearch PersonnelRespirationRoleSexual DysfunctionSignal TransductionSignal Transduction PathwaySite-Directed MutagenesisSmooth MuscleSpasmStriated MusclesStructureTechniquesTestingThickThin FilamentThinkingTissuesadrenergicbasecell motilitycell typecholinergicdesensitizationgastrointestinalhuman diseasein vivomouse genomenerve supplynovelprogramsreproductive functionresearch studyresponse
项目摘要
Smooth muscle plays an essential role in a wide variety of physiological processes, and although the
basic function of every smooth muscle is the same, to contract and relax, the mechanical properties and
responsiveness to hormones, neurotransmitters and drugs varies greatly between smooth muscle types.
Factors that dictate the contractile characteristics of smooth muscle include plasma membrane properties,
ratio and compliment of signal transducing proteins, the composition of the contractile apparatus itself.
Alteration in the normal blend of these components is thought to underlie the molecular basis of several
human diseases that involve smooth muscle including hypertension, bronco spasm, sexual dysfunction,
gastrointestinal disorders and glaucoma. It is our hypothesis that by studying the molecular processes by
which individual smooth muscles normally respond to stimulation will lead to more selective therapies to treat
these disorders. The recent completion of the human and mouse genomes in combination with advanced
techniques in mass spectrometry affords new opportunities for probing signal transduction pathways in cells.
In this proposal we will employ a unique combination of proteomics, muscle physiology, molecular biology,
immuno-histochemistry and mouse genetics to determine the molecular mechanisms by which cGMP
through the activation of cyclic GMP dependant protein kinase (PKG) regulates smooth muscle relaxation.
Examination of phosphoproteomes of various smooth muscles identified a distinct subset of early protein
targets for PKG. Several were identified in the mouse and human genome, including CHASM, a novel
protein containing a previously unidentified motif that is highly conserved in the smoothelin family of smooth
muscle specific proteins. When added to permeabilized smooth muscles, CHASM causes calcium
desensitization and relaxation in a phosphorylation dependant manner. The degree of sequence divergence
of the intervening non-conserved amino acids within the CHASM motif region suggests that CHASM and the
smoothelins may be part of a larger family of smooth muscle specific proteins that are important in the
mediating the actions of cGMP/PKG. To directly test this hypothesis we have deleted the CHASM gene and
obtained CHASM null mice.
平滑肌在多种生理过程中发挥着重要作用,尽管
每条平滑肌的基本功能都是相同的,即收缩和放松、机械性能和
平滑肌类型之间对激素、神经递质和药物的反应差异很大。
决定平滑肌收缩特性的因素包括质膜特性,
信号转导蛋白的比例和补充,收缩装置本身的组成。
这些成分正常混合的改变被认为是几种物质的分子基础。
涉及平滑肌的人类疾病包括高血压、野马痉挛、性功能障碍、
胃肠道疾病和青光眼。我们的假设是,通过研究分子过程
哪些个体平滑肌通常对刺激做出反应将导致更有选择性的治疗方法
这些疾病。最近完成的人类和小鼠基因组结合先进的
质谱技术为探测细胞信号转导途径提供了新的机会。
在这个提案中,我们将采用蛋白质组学、肌肉生理学、分子生物学、
免疫组织化学和小鼠遗传学以确定 cGMP 的分子机制
通过激活环 GMP 依赖性蛋白激酶 (PKG) 调节平滑肌松弛。
对各种平滑肌磷酸化蛋白质组的检查发现了早期蛋白质的独特子集
PKG 的目标。在小鼠和人类基因组中发现了几种,其中包括 CHASM,一种新型的
含有先前未识别的基序的蛋白质,该基序在平滑肌蛋白家族中高度保守
肌肉特异性蛋白质。当添加到透化的平滑肌中时,CHASM 会产生钙
以磷酸化依赖性方式脱敏和松弛。序列分歧程度
CHASM 基序区域内插入的非保守氨基酸表明 CHASM 和
平滑蛋白可能是平滑肌特异性蛋白大家族的一部分,这些蛋白在
介导 cGMP/PKG 的作用。为了直接检验这个假设,我们删除了 CHASM 基因并
获得 CHASM 无效小鼠。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY A HAYSTEAD其他文献
TIMOTHY A HAYSTEAD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY A HAYSTEAD', 18)}}的其他基金
Evaluating the Blood-Brain Barrier Bioavailability and in vivo Efficacy Potential of a Novel TAK1 Inhibitor Targeting Chronic Pain
评估针对慢性疼痛的新型 TAK1 抑制剂的血脑屏障生物利用度和体内疗效潜力
- 批准号:
10151730 - 财政年份:2021
- 资助金额:
$ 30.43万 - 项目类别:
Acute Inhibition of TAK1 as a Means to Control COVID-19 Pulmonary Hyperinflammation
急性抑制 TAK1 作为控制 COVID-19 肺部高炎症的方法
- 批准号:
10158054 - 财政年份:2021
- 资助金额:
$ 30.43万 - 项目类别:
Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis
TAK1 抑制剂 HS-276 用于治疗类风湿关节炎的临床前开发
- 批准号:
10259629 - 财政年份:2021
- 资助金额:
$ 30.43万 - 项目类别:
Acute Inhibition of TAK1 as a Means to Control COVID-19 Pulmonary Hyperinflammation
急性抑制 TAK1 作为控制 COVID-19 肺部高炎症的方法
- 批准号:
10458667 - 财政年份:2021
- 资助金额:
$ 30.43万 - 项目类别:
Improving the Oral Bioavailability and In vivo Efficacy of a Novel TAK1 Inhibitor Targeting Rheumatoid Arthritis
提高针对类风湿关节炎的新型 TAK1 抑制剂的口服生物利用度和体内疗效
- 批准号:
9904243 - 财政年份:2019
- 资助金额:
$ 30.43万 - 项目类别:
EVALUATE BLOOD FLOW LUNG, BRAIN, HEART, KIDNEY IN WILD-TYPE MICE W/ CONTRAST
通过对比评估野生型小鼠的肺、脑、心脏、肾的血流
- 批准号:
7358284 - 财政年份:2006
- 资助金额:
$ 30.43万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
成人与儿童结核病发展的综合研究:细菌菌株和周围微生物组的影响
- 批准号:81961138012
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:国际(地区)合作与交流项目
统计学习影响成人汉语二语学习的认知神经机制
- 批准号:31900778
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias
RyR 激动剂部分且受控地消耗 SR 钙可预防钙依赖性心律失常
- 批准号:
10577630 - 财政年份:2023
- 资助金额:
$ 30.43万 - 项目类别:
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 30.43万 - 项目类别:
Role of SIK3 in PKA/mTORC1 regulation of adipose browning
SIK3 在 PKA/mTORC1 调节脂肪褐变中的作用
- 批准号:
10736962 - 财政年份:2023
- 资助金额:
$ 30.43万 - 项目类别:
Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease Modeling
开发基于胶原蛋白的 3D 生物打印微流体平台,用于血管组织工程和疾病建模
- 批准号:
10837289 - 财政年份:2023
- 资助金额:
$ 30.43万 - 项目类别: